OLM Diagnostics
Developing the future of fungal diagnostics
OLM Diagnostics is acting to address the threat of antifungal resistance. The company is discovering and developing a new diagnostic-led approach to tackling fungal infections. Research and development drives OLM diagnostics' focus; to reinforce their reputation as a trusted healthcare partner and to enhance patient health outcomes.
Clinicians can have confidence in the sensitivity and specificity of OLM Diagnostics tests – to correctly identify true positive and true negative cases. Additionally, the tests are inexpensive and require no additional laboratory equipment.
Benefits of OLM fungal diagnostic tests:
- Reduced rate of drug resistant infections
- Preservation of existing antifungal medication
- Improvement to patient care through appropriate prescribing
- Potential cost savings to the NHS and healthcare institutions
- No extra costs or equipment required to run the diagnostic tests. Lab equipment already in place e.g. a PCR machine
OLM fungal diagnostic range:
- AspDx - detection of Aspergillus species
- CandDx - detection of Candida species
- PneumDx - detection of Pneumocystis jirovecii, a common cause of pneumonia and other respiratory infections
Biogenex
Molecular pathology systems
GenomeMe
IHC monoclonal antibodies
RayBiotech
Proteomic discovery tools
BBI Solutions
Diagnostic raw materials
Hillgene
Innovative products for cell and gene therapy